{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:29:09Z","timestamp":1769128149942,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:00:00Z","timestamp":1476316800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Serbian Ministry of Science","award":["175033"],"award-info":[{"award-number":["175033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40618-016-0561-2","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T13:53:32Z","timestamp":1476366812000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure"],"prefix":"10.1007","volume":"40","author":[{"given":"G.","family":"Loncar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cvetinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-D.","family":"Dungen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Radojicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Putnikovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Trippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"561_CR1","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:e391\u2013e479","journal-title":"Circulation"},{"key":"561_CR2","doi-asserted-by":"crossref","first-page":"e59225","DOI":"10.1371\/journal.pone.0059225","volume":"8","author":"D Tiller","year":"2013","unstructured":"Tiller D, Russ M, Greiser KH, Nuding S, Ebelt H, Kluttig A, Kors JA, Thiery J, Bruegel M, Haerting J, Werdan K (2013) Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study. PLoS One 8:e59225","journal-title":"PLoS One"},{"key":"561_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158","journal-title":"Lancet"},{"key":"561_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-008-0014-8","volume":"6","author":"LA Fitzpatrick","year":"2008","unstructured":"Fitzpatrick LA, Bilezikian JP, Silverberg SJ (2008) Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep 6:77\u201383","journal-title":"Curr Osteoporos Rep"},{"key":"561_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","volume":"37","author":"KD Schl\u00fcter","year":"1998","unstructured":"Schl\u00fcter KD, Piper HM (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37:34\u201341","journal-title":"Cardiovasc Res"},{"key":"561_CR6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s40618-015-0320-9","volume":"38","author":"T Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n T, Gonz\u00e1lez-Montalvo JI, Hoyos R, Diez-Sebasti\u00e1n J, Otero A, Mauleon JL (2015) Parathyroid hormone response to two levels of vitamin D deficiency is associated with high risk of medical problems during hospitalization in patients with hip fracture. J Endocrinol Invest 38:1129\u20131135","journal-title":"J Endocrinol Invest"},{"key":"561_CR7","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1007\/BF03347080","volume":"34","author":"G Loncar","year":"2011","unstructured":"Loncar G, Bozic B, Dimkovic S, Prodanovic N, Radojicic Z, Cvorovic V, Putnikovic B, Popovic V (2011) Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. J Endocrinol Invest 34:e78\u2013e85","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 1","key":"561_CR8","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.33549\/physiolres.932185","volume":"60","author":"B Bozic","year":"2011","unstructured":"Bozic B, Loncar G, Prodanovic N, Lepic T, Radojicic Z, Cvorovic V, Dimkovic S, Popovic V (2011) Parathyroid hormone response to vitamin D insufficiency in elderly males with chronic heart failure. Physiol Res 60(Suppl 1):S155\u2013S163","journal-title":"Physiol Res"},{"key":"561_CR9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10741-012-9336-9","volume":"18","author":"S Gandhi","year":"2013","unstructured":"Gandhi S, Myers RB (2013) Can parathyroid hormone be used as a biomarker, for heart failure? Heart Fail Rev 18:465\u2013473","journal-title":"Heart Fail Rev"},{"key":"561_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1074248410390214","volume":"16","author":"M Agarwal","year":"2011","unstructured":"Agarwal M, Phan A, Willix R Jr, Barber M, Schwarz ER (2011) Is vitamin D deficiency associated with heart failure? A review of current evidence. J Cardiovasc Pharmacol Ther 16:354\u2013363","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"561_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/hrt.2008.147652","volume":"95","author":"T Sugimoto","year":"2009","unstructured":"Sugimoto T, Tanigawa T, Onishi K, Fujimoto N, Matsuda A, Nakamori S, Matsuoka K, Nakamura T, Koji T, Ito M (2009) Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart 95:395\u2013398","journal-title":"Heart"},{"key":"561_CR12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejim.2013.09.011","volume":"24","author":"G Loncar","year":"2013","unstructured":"Loncar G, Bozic B, von Haehling S, D\u00fcngen HD, Prodanovic N, Lainscak M, Arandjelovic A, Dimkovic S, Radojicic Z, Popovic V (2013) Association of adiponectin with peripheral muscle status in elderly patients with heart failure. Eur J Intern Med 24:818\u2013823","journal-title":"Eur J Intern Med"},{"key":"561_CR13","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1046\/j.1523-1755.63.s85.11.x","volume":"85","author":"C G\u00f3mez-Alonso","year":"2003","unstructured":"G\u00f3mez-Alonso C, Naves-D\u00edaz ML, Fern\u00e1ndez-Mart\u00edn JL, D\u00edaz-L\u00f3pez JB, Fern\u00e1ndez-Coto MT, Cannata-And\u00eda JB (2003) Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl 85:S44\u2013S48","journal-title":"Kidney Int Suppl"},{"key":"561_CR14","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1253\/circj.CJ-14-0481","volume":"78","author":"T Sugimoto","year":"2014","unstructured":"Sugimoto T, Dohi K, Onishi K, Yamada T, Horiguchi M, Takamura T, Kawamura A, Seko T, Nakamura M, Kasai A, Ito M (2014) Prognostic value of serum parathyroid hormone level in acute decompensated heart failure. Circ J 78:2704\u20132710","journal-title":"Circ J"},{"key":"561_CR15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/AC.69.6.1000009","volume":"69","author":"E Belen","year":"2014","unstructured":"Belen E, Tipi FF, Aykan AC, Findik\u00e7io\u011flu U, Karaku\u015f G, Ye\u015fil A, Helvaci A, Kalaycio\u011flu E, Cetin M (2014) Clinical staging in chronic heart failure associated with low vitamin D and elevated parathormone levels. Acta Cardiol 69:665\u2013671","journal-title":"Acta Cardiol"},{"key":"561_CR16","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"561_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary (2002) Function Laboratories. ATS statement: guidelines for the 6-min walk test. Am J Respir Crit Care Med 166:111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"key":"561_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.echo.2008.12.013","volume":"22","author":"FE Silvestry","year":"2009","unstructured":"Silvestry FE, Kerber RE, Brook MM, Carroll JD, Eberman KM, Goldstein SA, Herrmann HC, Homma S, Mehran R, Packer DL, Parisi AF, Pulerwitz T, Seward JB, Tsang TS, Wood MA (2009) Echocardiography-guided interventions. J Am Soc Echocardiogr 22:213\u2013231","journal-title":"J Am Soc Echocardiogr"},{"key":"561_CR19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","volume":"124","author":"TS Rector","year":"1992","unstructured":"Rector TS, Cohn JN (1992) Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124:1017\u20131025","journal-title":"Am Heart J"},{"key":"561_CR20","doi-asserted-by":"crossref","first-page":"e001278","DOI":"10.1161\/JAHA.114.001278","volume":"3","author":"N Bansal","year":"2014","unstructured":"Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, Shoben AB, Peralta CA, Siscovick DS, Kestenbaum B, de Boer IH (2014) Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 3:e001278","journal-title":"J Am Heart Assoc"},{"key":"561_CR21","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.amjcard.2008.06.067","volume":"102","author":"DH Kim","year":"2008","unstructured":"Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ (2008) Prevalence of hypovitaminosis D in cardiovascular disease (from the National Health and Nutrition Examination Survey 2001\u20132004). Am J Cardiol 102:1540\u20131544","journal-title":"Am J Cardiol"},{"key":"561_CR22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.numecd.2010.01.002","volume":"20","author":"P Ameri","year":"2010","unstructured":"Ameri P, Ronco D, Casu M (2010) High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 20:633\u2013640","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"561_CR23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","volume":"13","author":"LL Schierbeck","year":"2011","unstructured":"Schierbeck LL, Jensen TS, Bang U, Jensen G, K\u00f8ber L, Jensen JE (2011) Parathyroid hormone and vitamin D: markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail 13:626\u2013632","journal-title":"Eur J Heart Fail"},{"key":"561_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","volume":"7","author":"SG Wannamethee","year":"2014","unstructured":"Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N (2014) Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 7:732\u2013739","journal-title":"Circ Heart Fail"},{"key":"561_CR25","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","volume":"58","author":"B Kestenbaum","year":"2011","unstructured":"Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58:1433\u20131441","journal-title":"J Am Coll Cardiol"},{"key":"561_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MA, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35:455\u2013469","journal-title":"Eur Heart J"},{"key":"561_CR27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cca.2014.03.029","volume":"433","author":"D Gruson","year":"2014","unstructured":"Gruson D, Buglioni A, Burnett JC Jr (2014) PTH: potential role in management of heart failure. Clin Chim Acta 433:290\u2013296","journal-title":"Clin Chim Acta"},{"key":"561_CR28","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","volume":"24","author":"FN Saleh","year":"2003","unstructured":"Saleh FN, Schirmer H, Sundsfjord J, Jorde R (2003) Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24:2054\u20132060","journal-title":"Eur Heart J"},{"key":"561_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3858\/emm.2010.42.1.006","volume":"42","author":"H Cha","year":"2010","unstructured":"Cha H, Jeong HJ, Jang SP, Kim JY, Yang DK, Oh JG, Park WJ (2010) Parathyroid hormone accelerates decompensation following left ventricular hypertrophy. Exp Mol Med 42:61\u201368","journal-title":"Exp Mol Med"},{"key":"561_CR30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","volume":"94","author":"A Tomaschitz","year":"2012","unstructured":"Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, Drechsler C, M\u00e4rz W, Ofner M, Pieber TR, Pilz S (2012) Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res 94:10\u201319","journal-title":"Cardiovasc Res"},{"key":"561_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","volume":"27","author":"MR Rutledge","year":"2013","unstructured":"Rutledge MR, Farah V, Adeboye AA, Seawell MR, Bhattacharya SK, Weber KT (2013) Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism. Cardiovasc Drugs Ther 27:161\u2013170","journal-title":"Cardiovasc Drugs Ther"},{"key":"561_CR32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z et al (2005) Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111:871\u2013878","journal-title":"Circulation"},{"key":"561_CR33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","volume":"46","author":"PH Law","year":"2005","unstructured":"Law PH, Sun Y, Bhattacharya SK, Chhokar VS, Weber KT (2005) Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol 46:142\u2013146","journal-title":"J Am Coll Cardiol"},{"key":"561_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.peptides.2014.12.010","volume":"64","author":"D Gruson","year":"2015","unstructured":"Gruson D, Ahn SA, Rousseau MF (2015) Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure. Peptides 64:24\u201328","journal-title":"Peptides"},{"key":"561_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjcard.2011.08.039","volume":"109","author":"H Altay","year":"2012","unstructured":"Altay H, Zorlu A, Binici S, Bilgi M, Yilmaz MB, Colkesen Y, Erol T, Muderrisoglu H (2012) Relation of serum parathyroid hormone level to severity of heart failure. Am J Cardiol 109:252\u2013256","journal-title":"Am J Cardiol"},{"key":"561_CR36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/heartjnl-2012-302779","volume":"99","author":"T Sugimoto","year":"2013","unstructured":"Sugimoto T, Dohi K, Onishi K, Watanabe K, Sato Y, Sugiura E, Nakamori S, Nakajima H, Nakamura M, Ito M (2013) Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure. Heart 99:111\u2013115","journal-title":"Heart"},{"key":"561_CR37","doi-asserted-by":"crossref","first-page":"e002254","DOI":"10.1136\/bmjopen-2012-002254","volume":"3","author":"C Bjurman","year":"2013","unstructured":"Bjurman C, Jensen J, Petzold M, Hammarsten O, Fu ML (2013) Assessment of a multimarker strategy for prediction of mortality in older heart failure patients: a cohort study. BMJ Open 3:e002254","journal-title":"BMJ Open"},{"key":"561_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.archger.2014.11.005","volume":"60","author":"S Zhang","year":"2015","unstructured":"Zhang S, Hu Y, Zhou L, Chen X, Wang Y, Wu J, He H, Gao Y (2015) Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF). Arch Gerontol Geriatr 60:359\u2013365","journal-title":"Arch Gerontol Geriatr"},{"key":"561_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MAJ.0b013e318134f013","volume":"335","author":"Y Selektor","year":"2008","unstructured":"Selektor Y, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT (2008) Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism. Am J Med Sci 335:105\u2013110","journal-title":"Am J Med Sci"},{"key":"561_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Dr\u00fceke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J (2015) Evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial investigators*. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation 132:27\u201339","journal-title":"Circulation"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0561-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T09:08:08Z","timestamp":1657444088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0561-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0561-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,13]]}}}